GSK Investigational Site

Latham, New York 12110

0 studies enrolling now · 3 studies all time

What they study most

Bipolar Disorder, Lung Cancer, Small Cell, Melanoma

Studies at this site

• A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor — Stopped early
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population — Stopped early